Right Hand Manager: SpendMetrix beta program.

EDP Weekly's IT Monitor | October 7, 2002 | Copyright

Right Hand Manager Software, a developer of next-generation analytical applications, has announced the beta program for its SpendMetrix performance and control tool for manufacturers' direct material purchasing.

With work already underway at the company's first beta sites, early interest in SpendMetrix' fine-grained financial analysis of direct materials purchasing is high. "The SpendMetrix proposition is straightforward," reflects Right Hand Manager Software CEO and Founder Sam Kinney. "If you know more about your spending, you spend less. For many manufacturers, ...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

Two new drugs for the treatment of Alzheimers disease are expected to enter the market by 2008.
M2 Presswire ; ...new drugs for the treatment of Alzheimers disease are expected to enter the market...DiseaseNecessary Attributes of Alzheimers Disease Biochemical MarkersEmerging Imaging Agents for Diagnosis of Alzheimers DiseaseKey Players in Alzheimers...
Healthful habits help in prevention, delay of Alzheimers disease.
News Wire article from: PPI - Pakistan Press International ; ...towards a cure for Alzheimers disease. As prevalence rates...to prevent and treat Alzheimers disease. If you are already...against Alzheimers disease. There are no brain...formulas, but the anti-Alzheimers fundamentals are health...
LILLY ADVANCES SECOND ALZHEIMERS DISEASE TREATMENT CANDIDATE.
News Wire article from: AsiaPulse News ; ...Lilly Advances Second Alzheimers Disease Treatment Candidate...Lillys commitment to Alzheimers disease and biotech...treatments for Alzheimer's disease can continue treatment...functional decline of Alzheimers disease patients as...
Two New Alzheimers Disease Studies Show Advances Against Different Treatment Targets
Newspaper article from: U.S. Newswire ; ...related to experimental Alzheimers therapies reported...today at the 2008 Alzheimers Association International...on Alzheimer's Disease (ICAD 2008) in...strategies to create disease modifying therapies for Alzheimers. In addition, for...
Co-Chairs of the Congressional Task Force on Alzheimers Disease Call on Presidential Candidates for Increased Attention to Diagnosis, Treatment of Dementia
Newspaper article from: U.S. Newswire ; ...Congressional Task Force on Alzheimers Disease, Rep. Edward Markey (D...consider the devastating impact of Alzheimers disease and related dementias...that are known risk factors for Alzheimers disease: 18 percent said they are depressed...
Curran launches policy study of Alzheimers disease care.
M2 Presswire ; ...launches policy study of Alzheimers disease care (C)1994-2001...policy issues related to Alzheimers disease. Currans project...diagnosed with Alzheimers disease should continue to drive...care for someone with Alzheimers disease and, in particular...
A New Phase in the Treatment of Alzheimers Disease is Expected to Begin in 2009 with the Launch of Drugs That Slow the Progression of the Disease - Alzhemed and Flurizan.
Business Wire ; ...announced the addition of Alzheimers Disease - Beta Treatments on...to their offering. Alzheimers patients remain poorly...individuals from Alzheimers disease subgroups or those more...patient segments in Alzheimers Disease for key late...
The Lack of Effective Treatments for Alzheimers Disease and an Aging Population Create an Enormous Opportunity for Disease-modifying Drugs.
M2 Presswire ; ...Treatments for Alzheimers Disease and an Aging Population...emergence of the first disease-modifying drugs...Pathophysiology of Alzheimers Disease Susceptibility...and Efficacy in Alzheimers Disease The Influence...Drug Efficacy in Alzheimers Disease Emerging...
United States: TheraGenetics Announces Agreement with Kings College London to Participate in AddNeuroMed Consortium to Identify Biomarkers for Alzheimers Disease.
News Wire article from: TendersInfo ; ...Consortium to identify biomarkers for Alzheimers disease that can be used to determine...undertake a pharmacogenetic study of Alzheimers patients treated with cholinesterase...tools, models and cohorts for Alzheimers disease biomarker discovery and validation...
Anti-Alzheimers Disease Drugs (Cholinesterase Inhibitors, and NMDARA), and Anti-Parkinsons Disease Drugs (Dopaminergic Agents, and Dopamine Agonists) are Classified inside 2006 Global Strategic Business Report.
M2 Presswire ; ...are Anti-Alzheimer's Disease Drugs (Cholinesterase...and Anti-Parkinson's Disease Drugs (Dopaminergic Agents...Outlook2. Neurodegenerative Diseases Market3. Alzheimers Market Overview4. Parkinsons Disease Market Overview5. Disease...

Find more facts and information related to the article "Right Hand Manager: SpendMetrix beta program."